Studies related to Creatinine and Bulbine natalensis

Short term safety of bulbine natalensis supplementation in healthy men
Effect Decrease
Trial Design cohort
Trial Length 24weeks
Number of Subjects 36
Sex m
Notes for this study:
Following 28 days supplementation with 750mg bulbine natalensis noted a small (2%) but statistically significant increase in the liver enzyme ALP which was deemed to be clinically irrelevant. (Note: Double blind protocol said to have been used, but full text with methodology not available; currently a poster presentation)
Funding issues for this study:
Funded by Sports Nutrition Research, the producer of the tested supplement (ProLensis)